Live Breaking News & Updates on Late Stage Emerging Therapies

Stay updated with breaking news from Late stage emerging therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032

Dublin, April 30, 2024 (GLOBE NEWSWIRE) The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the SYNAGIS for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report ....

United Kingdom , United States , Clinical Development , Market Insight , Topics Covered , Marketed Therapies , Late Stage Emerging Therapies , Respiratory Syncytial Virus , Market Size , The United Kingdom , Market Scenario , Market Assessment ,

REGN4461 (Mibavademab) for Lipodystrophy in 7MM: Market Size, Sales, Forecasts, and Emerging Insights 2019-2023, 2024-2032

Dublin, April 30, 2024 (GLOBE NEWSWIRE) The "REGN4461 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about REGN4461 for lipodystrophy in the seven major markets. A detailed picture of the REGN4461 for lipodystrophy in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report along ....

United Kingdom , United States , Clinical Development , Emerging Insight , Topics Covered , Marketed Therapies , Late Stage Emerging Therapies , Familial Partial Lipodystrophy , Market Size , The United Kingdom , Market Assessment ,

BRII-835 + BRII-179 for Chronic Hepatitis B in 7MM: Market Size, Forecast, and Emerging Insights 2019-2032

Dublin, April 22, 2024 (GLOBE NEWSWIRE) The "BRII-835 + BRII-179 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."BRII-835 + BRII-179 Market Size, Forecast, and Emerging Insight - 2032" report provides comprehensive insights about BRII-835 + BRII-179 for chronic hepatitis B in the seven major markets and China. A detailed picture of the BRII-835 + BRII-179 for chronic hepatitis B in the 7MM, i.e., the United States, EU4 (Germany, ....

Hong Kong , United States , United Kingdom , Brii Bio , Clinical Development , Emerging Insight , Enhanced Stabilization Chemistry Plus , Mainland China , China Hong Kong , Topics Covered , Marketed Therapies , Late Stage Emerging Therapies , Chronic Hepatitis B , Market Size ,